Yam JW - Search Results

1

ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma.

Tong M, Fung TM, Luk ST, Ng KY, Lee TK, Lin CH, Yam JW, Chan KW, Ng F, Zheng BJ, Yuan YF, Xie D, Lo CM, Man K, Guan XY, Ma S. Tong M, et al. Among authors: yam jw. Stem Cell Reports. 2015 Jul 14;5(1):45-59. doi: 10.1016/j.stemcr.2015.05.013. Epub 2015 Jun 18. Stem Cell Reports. 2015. PMID: 26095609 Free PMC article.

2

Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.

Ma APY, Yeung CLS, Tey SK, Mao X, Wong SWK, Ng TH, Ko FCF, Kwong EML, Tang AHN, Ng IO, Cai SH, Yun JP, Yam JWP. Ma APY, et al. Cancer Res. 2021 Jul 1;81(13):3679-3692. doi: 10.1158/0008-5472.CAN-20-3944. Epub 2021 May 11. Cancer Res. 2021. PMID: 33975883

3

Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.

Chan DW, Chan CY, Yam JW, Ching YP, Ng IO. Chan DW, et al. Among authors: yam jw. Gastroenterology. 2006 Oct;131(4):1218-27. doi: 10.1053/j.gastro.2006.07.020. Epub 2006 Jul 24. Gastroenterology. 2006. PMID: 17030191

4

Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.

Cai PC, Shi L, Liu VW, Tang HW, Liu IJ, Leung TH, Chan KK, Yam JW, Yao KM, Ngan HY, Chan DW. Cai PC, et al. Among authors: yam jw. Oncotarget. 2014 Sep 15;5(17):7549-62. doi: 10.18632/oncotarget.2273. Oncotarget. 2014. PMID: 25277189 Free PMC article.

5

Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells.

Lam SS, Mak AS, Yam JW, Cheung AN, Ngan HY, Wong AS. Lam SS, et al. Among authors: yam jw. Mol Ther. 2014 Apr;22(4):743-51. doi: 10.1038/mt.2014.1. Epub 2014 Jan 14. Mol Ther. 2014. PMID: 24419103 Free PMC article.

6

Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star.

Zheng W, Ji D, Zhou Y, Yu L, Huang P, Zheng Y, Meng N, Wang H, Bai X, Huang Z, Chen W, Yam JWP, Xu Y, Cui Y. Zheng W, et al. Mol Cancer Ther. 2021 Oct;20(10):1777-1788. doi: 10.1158/1535-7163.MCT-21-0363. Epub 2021 Aug 10. Mol Cancer Ther. 2021. PMID: 34376575 Review.

7

Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.

Shum CK, Lau ST, Tsoi LL, Chan LK, Yam JW, Ohira M, Nakagawara A, Tam PK, Ngan ES. Shum CK, et al. Among authors: yam jw. Oncogene. 2013 Aug 29;32(35):4086-99. doi: 10.1038/onc.2012.437. Epub 2012 Oct 8. Oncogene. 2013. PMID: 23045286

8

c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2.

Tang MK, Zhou HY, Yam JW, Wong AS. Tang MK, et al. Among authors: yam jw. Neoplasia. 2010 Feb;12(2):128-38. doi: 10.1593/neo.91438. Neoplasia. 2010. PMID: 20126471 Free PMC article.

9

Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.

Liu MX, Siu MK, Liu SS, Yam JW, Ngan HY, Chan DW. Liu MX, et al. Among authors: yam jw. Oncotarget. 2014 Feb 28;5(4):944-58. doi: 10.18632/oncotarget.1458. Oncotarget. 2014. PMID: 24659709 Free PMC article.

10

Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.

Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL. Wong SC, et al. Among authors: yam jw. J Pathol. 2002 Feb;196(2):145-53. doi: 10.1002/path.1035. J Pathol. 2002. PMID: 11793365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters